Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome
Key facts
- Who runs it
- Central Hospital, Nancy, France
- Where
- France25 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 3
- People taking part
- 4,336 people, planned
- Started
- Jun 2026
- Expected to end
- Jul 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Epinephrine 0.5 mg intravenous bolus
- Epinephrine 1 mg intravenous bolus
- Record updated
- 2 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Male or female, aged ≥18 years. Out-of-hospital cardiac arrest for which resuscitation is decided by the SMUR team
- Medical Out-of-hospital cardiac arrest. Affiliated with or beneficiary of a social security plan
Who cannot take part
- Non-medical Out-of-hospital cardiac arrest (traumatic, drownings, electrocution, asphyxia, overdose, unknown cause)
- Out-of-hospital cardiac arrest without advanced life support (Do Not Attempt Resuscitation order, body finding, the decision not to attempt advanced life support is at the physician's discretion); Pregnant women, birthing or breastfeeding mothers; Adults under legal protection measure (such as guardianship, conservatorship); Individuals deprived of liberty due to judicial or administrative decision
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study will test whether a lower dose of epinephrine (0.5 mg) given during emergency treatment for out-of-hospital cardiac arrest helps more patients survive with good brain function, compared to the standard dose (1 mg). Adults who experience cardiac arrest outside the hospital and are treated by emergency medical teams will be randomly assigned to receive either the low dose or the standard dose of epinephrine. The study will compare survival and neurological outcomes between the two groups over 28 days.
The 2 groups in the trial
- Epinephrine 0.5 mg intravenous bolus every 3-5 minutes during Cardio-Pulmonary ResuscitationTreatment being tested
Treatment: Epinephrine 0.5 mg intravenous bolus
- Epinephrine 1 mg IV bolus every 3-5 minutes during Cardio-Pulmonary ResuscitationExisting treatment, for comparison
Epinephrine 1 mg intravenous bolus every 3-5 minutes during Cardio-Pulmonary Resuscitation
Treatment: Epinephrine 1 mg intravenous bolus
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome: A Multicenter Randomized and Double-blind Trial.
- Record updated
- 2 March 2026